Skip to main content
. 2021 Aug 25;15(1):118–129. doi: 10.1111/cts.13126

FIGURE 1.

FIGURE 1

Study design. A single‐center, open‐label, single sequence, cross‐over study to investigate the effect of ritonavir and grapefruit juice on the pharmacokinetics of intravenous and oral remibrutinib. EOS, end of study; GFJ, grapefruit juice; PK, pharmacokinetic; RTV, ritonavir; SIL‐remibrutinib, stable isotope labeled remibrutinib